Wegovy and Cough: Is Semaglutide the Cause?

Three weeks in, a dry tickle that won't quit

Picture the scenario: you started Wegovy a few weeks ago, nausea has mostly settled, and you're losing weight steadily. Then a dry, irritating cough appears — not a cold, not a new chest infection, just a persistent tickle that catches you off guard in the middle of conversations. Naturally, you wonder whether your weekly injection is behind it.

The honest answer is: possibly, but indirectly. Semaglutide slows gastric emptying as part of how it reduces appetite. For some people, that slowing allows stomach acid to travel upward more easily, producing or worsening gastro-oesophageal reflux. Reflux that reaches the throat and upper airway is a well-recognised trigger for a chronic dry cough, even when the person feels little or no actual heartburn. Indigestion and reflux appear in semaglutide's documented side-effect profile precisely because of this gastric-motility effect, as the NHS medicines page for semaglutide notes.

So the cough itself is not being caused by semaglutide acting on the lungs. Rather, it can be an upstream consequence of reflux, which semaglutide genuinely can cause or worsen. That distinction matters when you're deciding what to do next.

Why ruling out other causes still matters

A cough that coincides with starting a new medicine is easy to attribute to that medicine, but the timing can be coincidental. A persistent cough in an adult has a long list of possible causes: seasonal allergies, post-nasal drip, asthma, a respiratory infection, or (particularly if you are a current or former smoker) something that warrants investigation in its own right. The question of whether Wegovy directly causes a cough is genuinely nuanced, and a clinician's job is to work through the differential rather than assume it is always or never the medicine.

If the cough is accompanied by wheezing, shortness of breath, blood in sputum, chest pain, or a fever, seek medical attention promptly, these symptoms point away from simple reflux and need assessment. A cough that persists beyond three weeks without an obvious cause should also be reviewed by your GP or the prescriber managing your treatment, regardless of whether you are on Wegovy or any other medicine.

For people who do develop reflux on semaglutide, practical adjustments often help: smaller meals, avoiding lying down for a couple of hours after eating, and cutting back on coffee and acidic foods. Your prescriber can also consider whether a dose pause or slower titration would reduce the GI burden while your body adjusts.

How the evidence landscape looks right now

Formal clinical trials for semaglutide at the 2.4 mg dose (including the STEP 1 study, published in the New England Journal of Medicine) tracked adverse events across thousands of participants, and cough was not flagged as a statistically notable finding. That does not mean no one reported it; trial-level data captures events that reach statistical significance, while post-marketing surveillance and patient reporting fill in the rest of the picture.

The MHRA's Yellow Card scheme exists precisely for this reason. If you experience a symptom you believe may be linked to your treatment, reporting it via Yellow Card contributes to the ongoing safety monitoring of all licensed medicines in the UK, including Wegovy. Real-world reports help regulators detect patterns that trials may not have been powered to identify. It is worth doing, it takes about ten minutes, and the data genuinely informs future safety guidance.

There is a separate question worth raising if you use an ACE inhibitor for blood pressure, a drug class that notoriously causes a dry, persistent cough in a significant minority of users. Starting a weight-loss medicine at the same time as an ACE inhibitor, or joining a programme while already taking one, can make the true source of a cough difficult to unpick without clinical input, and people who are living with MS and considering Wegovy face a similarly layered picture when it comes to separating medication effects from underlying condition symptoms. Semaglutide and cough overlaps with this exact scenario more than most people realise.

What to do if the cough continues

The practical steps are straightforward. Note when the cough started relative to your Wegovy dose, did it appear within a few days of a dose increase, or has it been there since the beginning? That timing is genuinely useful information for a clinician. Also note whether it is worse after eating, when lying flat, or first thing in the morning: those patterns point strongly toward reflux rather than a purely respiratory cause.

Do not stop your Wegovy injection without speaking to your prescriber first. A cough alone, in the absence of serious accompanying symptoms, is not a reason to abandon a treatment that may be meaningfully benefiting your health. Your prescriber can weigh the picture and advise on whether a change in approach makes sense. If you have been wondering whether Wegovy can be bought over the counter, our guidance explains why it remains a prescription-only medicine and what that means for how you access ongoing support. If you are thinking about how treatment costs and support fit together, our weight-loss treatment overview explains what a full private programme looks like.

Unexplained or worsening symptoms of any kind (cough included) deserve a proper conversation. The prescribers at nume offer priority aftercare seven days a week, so you are not left managing unexpected symptoms alone. A real clinician reads every message; your question does not go into a chatbot queue. Speak to our prescribers if you have concerns about any symptom that appears during your treatment.